News
Merck KGaA agreed to a deal with RNA biotech Skyhawk Therapeutics that could top out at $2 billion. Roche’s Genentech terminated a cell therapy partnership with Adaptive Biotechnologies, ending what ...
Novo Nordisk's economic moat is eroding due to increased competition and US drug price pressures, but growth in international ...
“Semaglutide has been in the US for more than eight years now. In India also, the oral version of this molecule is there for ...
Certain batches of injectable medicines, including insulin and weight-loss drugs, were reported stolen in transit. Experts ...
The regulator in its health alert letter mentioned that these stolen drugs are rDNA injectables that require strict ...
The products reported missing include insulin formulations marketed as Ryzodeg FlexTouch and Fiasp (Penfill and FlexTouch), ...
Novo Nordisk raced to meet demand for its weight-loss drug Wegovy and almost doubled its workforce over five years. Now, the ...
The most profitable trades in history often begin in moments of panic. And few moments felt more hopeless than the fall of 2008… As more and more borrowers began defaulting on their mortgages, the ...
Pedersen and Maggie Fick COPENHAGEN (Reuters) -As Novo Nordisk's sales of its blockbuster weight-loss drug Wegovy boomed, the ...
As Novo Nordisk's sales of its blockbuster weight-loss drug Wegovy boomed, the Danish drugmaker raced to expand manufacturing ...
Telehealth company Ro has tapped tennis star Serena Williams as a celebrity patient ambassador for its weight-loss treatments, the company said Thursday.
No one stays on top forever. It’s a lesson that Ozempic maker Novo Nordisk may be painfully learning about. The Danish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results